SeattleOfficeMagnoliaNeurosciences$12.3MillionNIDAGrantColumbiaUniversitySingaporeOfficeReviewed >4,000Opportunities(BARDA)– onupdatedslide deckLeroyHood,M.D.,Ph.D.AbbvieNon-DilutiveFundingApogenBiotechnologiesGatesFoundationExceptionalTrackRecordPetraPharmaTheRockefellerUniversityLodoTherapeuticsTargetedTherapeutic(Asset)Financing58.43%IRRLydianNeurosciencesTop-tierInvestorsTachiYamada,M.D.MDAndersonCancerCenterAlexandriaVentureInvestmentsHarvardMedicalSchoolNeuroscience& NeurologyAdvisory&CorporateBoards150+Years’ExperienceWRFCapitalCaseWesternReserveStrategicPartnershipsPfizerVentures1.02DPICPRITTurn-KeyFacilities2014 Top-quartileRankedUniversityofMinnesotaOncology$1 BillionGenentechCollaborationBruceL.A.Carter,Ph.D.GeneYeo,Ph.D.DivestituresEliLillyCapital-efficiency$3.375BillionExitSubstantialExitHistory2.85DVPIUniformedServicesUniversityNewYorkOfficeJanLundberg,Ph.D.EmployeesDanaFarberCancerRodeoTherapeuticsPronirasARCHVenturePartnersWeillCornellMedicineAcademic&ResearchInstitutionsPennStateAI &MachineLearningTemasekScientificExpertiseSteveGillis,Ph.D.SundarKodiyalamCorporateSpinoutsSanDiegoOfficeScientists&TechnologyDevelopersDiversityCSABMembers?UTSouthwesternMedicalCenterOperatingPartners?WuXiPharmaTechEntrepreneursSyndicationPartnersSeattleOfficeMagnoliaNeurosciences$12.3MillionNIDAGrantColumbiaUniversitySingaporeOfficeReviewed >4,000Opportunities(BARDA)– onupdatedslide deckLeroyHood,M.D.,Ph.D.AbbvieNon-DilutiveFundingApogenBiotechnologiesGatesFoundationExceptionalTrackRecordPetraPharmaTheRockefellerUniversityLodoTherapeuticsTargetedTherapeutic(Asset)Financing58.43%IRRLydianNeurosciencesTop-tierInvestorsTachiYamada,M.D.MDAndersonCancerCenterAlexandriaVentureInvestmentsHarvardMedicalSchoolNeuroscience& NeurologyAdvisory&CorporateBoards150+Years’ExperienceWRFCapitalCaseWesternReserveStrategicPartnershipsPfizerVentures1.02DPICPRITTurn-KeyFacilities2014 Top-quartileRankedUniversityofMinnesotaOncology$1 BillionGenentechCollaborationBruceL.A.Carter,Ph.D.GeneYeo,Ph.D.DivestituresEliLillyCapital-efficiency$3.375BillionExitSubstantialExitHistory2.85DVPIUniformedServicesUniversityNewYorkOfficeJanLundberg,Ph.D.EmployeesDanaFarberCancerRodeoTherapeuticsPronirasARCHVenturePartnersWeillCornellMedicineAcademic&ResearchInstitutionsPennStateAI &MachineLearningTemasekScientificExpertiseSteveGillis,Ph.D.SundarKodiyalamCorporateSpinoutsSanDiegoOfficeScientists&TechnologyDevelopersDiversityCSABMembers?UTSouthwesternMedicalCenterOperatingPartners?WuXiPharmaTechEntrepreneursSyndicationPartners

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
O
2
I
3
O
4
O
5
N
6
B
7
B
8
O
9
I
10
O
11
G
12
B
13
I
14
N
15
N
16
I
17
O
18
G
19
N
20
B
21
O
22
I
23
B
24
N
25
N
26
I
27
B
28
N
29
I
30
G
31
I
32
O
33
N
34
G
35
O
36
B
37
I
38
O
39
N
40
I
41
O
42
G
43
B
44
G
45
I
46
B
47
G
48
G
49
G
50
I
51
I
52
O
53
B
54
O
55
B
56
B
57
N
58
G
59
O
60
N
61
G
62
B
63
G
64
B
65
N
66
N
67
B
68
G
69
I
70
G
71
I
72
N
  1. O-Seattle Office
  2. I-Magnolia Neurosciences
  3. O-$12.3 Million NIDA Grant
  4. O-Columbia University
  5. N-Singapore Office
  6. B-Reviewed > 4,000 Opportunities
  7. B-(BARDA) – on updated slide deck
  8. O-Leroy Hood, M.D., Ph.D.
  9. I-Abbvie
  10. O-Non-Dilutive Funding
  11. G-Apogen Biotechnologies
  12. B-Gates Foundation
  13. I-Exceptional Track Record
  14. N-Petra Pharma
  15. N-The Rockefeller University
  16. I-Lodo Therapeutics
  17. O-Targeted Therapeutic (Asset) Financing
  18. G-58.43% IRR
  19. N-Lydian Neurosciences
  20. B-Top-tier Investors
  21. O-Tachi Yamada, M.D.
  22. I-MD Anderson Cancer Center
  23. B-Alexandria Venture Investments
  24. N-Harvard Medical School
  25. N-Neuroscience & Neurology
  26. I-Advisory & Corporate Boards
  27. B-150+ Years’ Experience
  28. N-WRF Capital
  29. I-Case Western Reserve
  30. G-Strategic Partnerships
  31. I-Pfizer Ventures
  32. O-1.02 DPI
  33. N-CPRIT
  34. G-Turn-Key Facilities
  35. O-2014 Top-quartile Ranked
  36. B-University of Minnesota
  37. I-Oncology
  38. O-$1 Billion Genentech Collaboration
  39. N-Bruce L.A. Carter, Ph.D.
  40. I-Gene Yeo, Ph.D.
  41. O-Divestitures
  42. G-Eli Lilly
  43. B-Capital-efficiency
  44. G-$3.375 Billion Exit
  45. I-Substantial Exit History
  46. B-2.85 DVPI
  47. G-Uniformed Services University
  48. G-New York Office
  49. G-Jan Lundberg, Ph.D.
  50. I-Employees
  51. I-Dana Farber Cancer
  52. O-Rodeo Therapeutics
  53. B-Proniras
  54. O-ARCH Venture Partners
  55. B-Weill Cornell Medicine
  56. B-Academic & Research Institutions
  57. N-Penn State
  58. G-AI & Machine Learning
  59. O-Temasek
  60. N-Scientific Expertise
  61. G-Steve Gillis, Ph.D.
  62. B-Sundar Kodiyalam
  63. G-Corporate Spinouts
  64. B-San Diego Office
  65. N-Scientists & Technology Developers
  66. N-Diversity
  67. B-CSAB Members?
  68. G-UT Southwestern Medical Center
  69. I-Operating Partners?
  70. G-WuXi PharmaTech
  71. I-Entrepreneurs
  72. N-Syndication Partners